Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6238-30-8

Post Buying Request

6238-30-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6238-30-8 Usage

Description

3-Hydroxyquinuclidine-3-carbonitrile is a chemical compound that serves as a crucial intermediate in the pharmaceutical industry. It is a derivative of quinuclidine, characterized by a bicyclic amine structure with a five-membered nitrogen-containing ring. 3-HYDROXYQUINUCLIDINE-3-CARBONITRILE is distinguished by its unique structure and chemical properties, which make it a valuable building block for the synthesis of a diverse array of biologically active molecules, particularly in the development of drugs targeting central nervous system disorders.

Uses

Used in Pharmaceutical Industry:
3-Hydroxyquinuclidine-3-carbonitrile is used as a key intermediate for the synthesis of various organic compounds, specifically in the production of pharmaceutical drugs. Its role is pivotal in creating molecules that address central nervous system disorders, leveraging its unique structural attributes to facilitate the development of effective treatments.
Used in Drug Discovery and Development:
In the realm of drug discovery and development, 3-Hydroxyquinuclidine-3-carbonitrile is utilized as a building block to create a wide range of biologically active molecules. Its chemical properties allow for the design and synthesis of new pharmaceutical agents, contributing to the advancement of medicinal chemistry and the treatment of various conditions related to the central nervous system.

Check Digit Verification of cas no

The CAS Registry Mumber 6238-30-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,3 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6238-30:
(6*6)+(5*2)+(4*3)+(3*8)+(2*3)+(1*0)=88
88 % 10 = 8
So 6238-30-8 is a valid CAS Registry Number.
InChI:InChI=1/C19H16N4O4S2/c24-8-6-20-16-13(17(25)22-7-2-1-5-15(22)21-16)10-14-18(26)23(19(28)29-14)11-12-4-3-9-27-12/h1-5,7,9-10,20,24H,6,8,11H2

6238-30-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Hydroxyquinuclidine-3-carbonitrile

1.2 Other means of identification

Product number -
Other names 3-hydroxy-1-azabicyclo[2.2.2]octane-3-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6238-30-8 SDS

6238-30-8Relevant articles and documents

NOVEL SPIRO-QUINUCLIDINYL DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

-

Page/Page column 25, (2010/11/30)

The present invention is directed to novel spiro-quinuclidinyl derivatives, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.

Novel spiro-quinuclidinyl derivatives for the treatment of central nervous system disorders

-

Page/Page column 8, (2010/11/25)

The present invention is directed to novel spiro-quinuclidinyl derivatives, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.

Novel 5-HT3 antagonists: Indol-3-ylspiro(azabicycloalkane-3,5'(4'H)- oxazoles)

Swain,Baker,Kneen,Herbert,Moseley,Saunders,Seward,Stevenson,Beer,Stanton,Watling,Ball

, p. 1019 - 1031 (2007/10/02)

The synthesis and biochemical evaluation of a series of spirofused indole oxazoline 5-HT3 antagonists is described in which the oxazoline ring acts as a bioisosteric replacement for esters and amides. The effect of substitution about the indole ring has shown the steric limitations of the aromatic binding site. Incorporation of a variety of azabicyclic systems within the rigid spirofused framework has allowed the definition of a binding model which incorporates a number of known antagonists and agonists. In this model steric constraints limit substitution around the indole ring although there is some bulk tolerance at the 1- and 2-positions. The importance of constraining the basic nitrogen within an azabicyclic system is underlined by comparison with the monocyclic piperidine. The highest affinity was observed for those compounds in which the basic nitrogen occupies a bridgehead position, the most potent analogue in this group being the azabicyclic [3.3.1] system (pIC50 = 8.95), suggesting lipophilic interactions may play a role in increasing affinity. A suggested model for agonist binding is included in which the basic nitrogens are superimposed and the 5-hydroxyl group of 5-HT is superimposed on the H-bond-accepting atom of the heterocyclic linking group.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6238-30-8